Urso 250 and Pneumonia staphylococcal - a phase IV clinical study of FDA data

Summary:

Pneumonia staphylococcal is reported as a side effect among people who take Urso 250 (ursodiol), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Prednisolone, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Pneumonia staphylococcal when taking Urso 250. It is created by eHealthMe based on reports of 5,057 people who have side effects when taking Urso 250 from the FDA, and is updated regularly.

What is Urso 250?

Urso 250 has active ingredients of ursodiol. eHealthMe is studying from 5,080 Urso 250 users. Check the latest studies of Urso 250.

What is Pneumonia staphylococcal?

Pneumonia staphylococcal (pneumonia staphylococcal infections are usually caused by the organism staphylococcus aureus) is found to be associated with 446 drugs and 564 conditions by eHealthMe. Check the latest studies of Pneumonia staphylococcal.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 29, 2026

5,057 people reported to have side effects when taking Urso 250.
Among them, 12 people (0.24%) have Pneumonia staphylococcal.

Could Urso 250 cause Pneumonia staphylococcal?

Among these 12 people:

How long have people been on Urso 250 when they have Pneumonia staphylococcal? *

  • < 1 month: 71.43 %
  • 1 - 6 months: 28.57 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Pneumonia staphylococcal when taking Urso 250? *

  • female: 58.33 %
  • male: 41.67 %

What is the age of people who have Pneumonia staphylococcal when taking Urso 250? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 20 %
  • 60+: 80 %

What are other drugs people take besides Urso 250? *

  1. Lansoprazole: 3 people, 25.00%
  2. Magnesium Oxide: 3 people, 25.00%
  3. Prednisolone: 3 people, 25.00%
  4. Maxipime: 2 people, 16.67%
  5. Mylotarg: 2 people, 16.67%
  6. Allopurinol: 2 people, 16.67%
  7. Clarithromycin: 2 people, 16.67%
  8. Famotidine: 2 people, 16.67%
  9. Kytril: 2 people, 16.67%
  10. Lasix: 2 people, 16.67%

What are other side effects people have besides Pneumonia staphylococcal? *

  1. Ards (Acute Respiratory Distress Syndrome) (sudden failure of the respiratory (breathing) system): 4 people, 33.33%
  2. Blood Lactate Dehydrogenase Increased: 3 people, 25.00%
  3. Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 3 people, 25.00%
  4. Back Pain: 2 people, 16.67%
  5. Infection: 2 people, 16.67%
  6. Cardio-Respiratory Arrest (sudden dysfunction of heart and lungs): 2 people, 16.67%
  7. Hypoaesthesia (reduced sense of touch or sensation): 2 people, 16.67%
  8. Lung Infection Pseudomonal (bacterial infection of lung by pseudomonas aeruginosa): 2 people, 16.67%
  9. Dehydration (dryness resulting from the removal of water): 2 people, 16.67%
  10. Weakness: 2 people, 16.67%

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 25.00%
  2. Renal Disorder (kidney disease): 2 people, 16.67%
  3. Lung Adenocarcinoma (a form of non-small cell lung cancer): 2 people, 16.67%
  4. Histiocytosis Haematophagic: 2 people, 16.67%
  5. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 2 people, 16.67%
  6. Febrile Neutropenia (fever with reduced white blood cells): 2 people, 16.67%
  7. Acute Myeloid Leukaemia Recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent): 2 people, 16.67%
  8. Multiple Myeloma (cancer of the plasma cells): 1 person, 8.33%
  9. Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 1 person, 8.33%
  10. Hepatitis B: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Urso 250 and have Pneumonia staphylococcal?

- Check whether Pneumonia staphylococcal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Urso 250:

Pneumonia staphylococcal treatments and more:

How severe was Pneumonia staphylococcal and when was it recovered:

Expand to all the drugs that have ingredients of ursodiol:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Urso 250:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pneumonia staphylococcal:

Browse all the conditions that are associated with Pneumonia staphylococcal:


How the study uses the data?

The study uses data from the FDA. It is based on ursodiol (the active ingredients of Urso 250) and Urso 250 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: